Pertussis outbreaks and pertussis vaccines: New insights, new concerns, new recommendations?

Vaccine

Volumn 30, Issue 49, 2012, Pages 6957-6959

  Poland, Gregory A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIMBRIA PROTEIN; HEMAGGLUTININ; PERTACTIN; PERTUSSIS TOXIN; PERTUSSIS VACCINE;

BORDETELLA PERTUSSIS; CELLULAR IMMUNITY; DISEASE PREDISPOSITION; EDITORIAL; EPIDEMIC; HERD IMMUNITY; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; PERTUSSIS; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; TH1 TH2 BALANCE;

ADULT; AGED; AGED, 80 AND OVER; BORDETELLA PERTUSSIS; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FEMALE; HUMANS; INFANT; MALE; PERTUSSIS VACCINE; PREGNANCY; TREATMENT FAILURE; UNITED STATES; WHOOPING COUGH;

EID: 84869004887     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.09.084     Document Type: Editorial

References (17)

1. Pertussis epidemic - Washington, 2012. MMWR Morb Mortal Wkly Rep 2012, 61(July):517-522.
2. Poland G.A., Jacobson R.M. The clinician's guide to the anti-vaccinationists' galaxy. Hum Immunol 2012, 73(April (8)):859-866.
3. Poland G.A., Jacobson R.M. Understanding those who do not understand: a brief review of the anti-vaccine movement. Vaccine 2001, 19:2440-2445.
4. Poland C.M., Poland G.A. Vaccine education spectrum disorder: the importance of incorporating psychological and cognitive models into vaccine education. Vaccine 2011, 29(August (37)):6145-6148.
5. Mills K.H. Immunity to Bordetella pertussis. Microbes Infect 2001, 3(July (8)):655-677.
6. Witt M.A., Katz P.H., Witt D.J. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. Clin Infect Dis 2012, 54(June (12)):1730-1735.
7. Klein N.P., Bartlett J., Rowhani-Rahbar A., Fireman B., Baxter R. Waning protection after fifth dose of acellular pertussis vaccine in children. N Engl J Med 2012, 367(September (11)):1012-1019.
8. Sheridan S.L., Ware R.S., Grimwood K., Lambert S.B. Number and order of whole cell pertussis vaccines in infancy and disease protection. J Am Med Assoc 2012, 308(5):454-456.
9. Mascart F., Hainaut M., Peltier A., Verscheure V., Levy J., Locht C. Modulation of the infant immune responses by the first pertussis vaccine administrations. Vaccine 2007, 25(January (2)):391-398.
10. Rowe J., Macaubas C., Monger T.M., Holt B.J., Harvey J., Poolman J.T., et al. Antigen-specific responses to diphtheria-tetanus-acellular pertussis vaccine in human infants are initially Th2 polarized. Infect Immun 2000, 68(July (7)):3873-3877.
11. Octavia S., Sintchenko V., Gilbert G.L., Lawrence A., Keil A.D., Hogg G., et al. Newly emerging clones of Bordetella pertussis carrying prn2 and ptxP3 alleles implicated in Australian pertussis epidemic in 2008-2010. J Infect Dis 2012, 205(April (8)):1220-1224.
12. Mooi F.R. Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen. Infect Genet Evol 2010, 10(January (1)):36-49.
13. Octavia S., Maharjan R.P., Sintchenko V., Stevenson G., Reeves P.R., Gilbert G.L., et al. Insight into evolution of Bordetella pertussis from comparative genomic analysis: evidence of vaccine-driven selection. Mol Biol Evol 2011, 28(January (1)):707-715.
14. Kurniawan J., Maharjan R.P., Chan W.F., Reeves P.R., Sintchenko V., Gilbert G.L., et al. Bordetella pertussis clones identified by multilocus variable-number tandem-repeat analysis. Emerg Infect Dis 2010, 16(February (2)):297-300.
15. Mooi F.R., van Loo I.H., van G.M., He Q., Bart M.J., Heuvelman K.J., et al. Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg Infect Dis 2009, 15(August (8)):1206-1213.
16. Mooi F.R., van O.H., Heuvelman K., van der Heide H.G., Gaastra W., Willems R.J. Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect Immun 1998, 66(February (2)):670-675.
17. Mertsola J., Van Der Meeren O., He Q., Linko-Parvinen A., Ramakrishnan G., Mannermaa L., et al. Decennial administration of a reduced antigen content diphtheria and tetanus toxoids and acellular pertussis vaccine in young adults. Clin Infect Dis 2010, 51(September (6)):656-662.